This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Chain Biotechnology Limited, Dana-Farber-Cancer Institute Inc., Isis Innovation Limited. Active years: 2016-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2016-2025
Title: Shisong Jiang: Innovator in Oligopeptide Synthesis
Introduction
Shisong Jiang is a notable inventor based in Oxford, GB. He has made significant contributions to the field of biochemistry, particularly in the synthesis of oligopeptides. His innovative approach has implications for vaccine development and epitope mapping.
Latest Patents
Shisong Jiang holds a patent for a process for making oligopeptides. This patent describes a method for synthesizing a family of oligopeptides with predetermined amino acid sequences. The process involves creating a nucleic acid construct that codes for a fusion protein composed of overlapping peptides derived from a target protein. The method includes expressing the nucleic acid construct in a suitable expression vector, harvesting the fusion protein, and digesting it with a protease to generate the oligopeptides. These oligopeptides can be utilized as vaccines against viral infections and in epitope mapping.
Career Highlights
Throughout his career, Shisong Jiang has worked with prominent organizations such as Isis Innovation Limited and Dana-Farber Cancer Institute Inc. His work has been instrumental in advancing the understanding and application of oligopeptides in medical research.
Collaborations
Shisong Jiang has collaborated with notable professionals in his field, including Ruth M. Ruprecht. These collaborations have further enhanced the impact of his research and innovations.
Conclusion
Shisong Jiang's contributions to the synthesis of oligopeptides represent a significant advancement in biochemistry. His innovative methods have the potential to influence vaccine development and improve our understanding of protein interactions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile